about
Technology-Delivered Mental Health Interventions for People Living with HIV/AIDS (PLWHA): a Review of Recent AdvancesUse of highly active antiretroviral therapy in a cohort of HIV-seropositive womenEffects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected personsIllicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenDepressive symptoms and antiretroviral therapy (ART) initiation among HIV-infected Russian drinkers.Mental health treatment to reduce HIV transmission risk behavior: a positive prevention modelSymptoms of psychological distress: a comparison of rural and urban individuals enrolled in HIV-related mental health care.Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression.Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient populationClinicians, educators, and investigators in general internal medicine: bridging the gapsInitiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression.Feasibility of telephone-based cognitive behavioral therapy targeting major depression among urban dwelling African-American people with co-occurring HIVA marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVHIV patients with psychiatric disorders are less likely to discontinue HAART.Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS.A closer look at depression and its relationship to HIV antiretroviral adherence.Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential.Health Outcomes of HIV-Infected People with Mental Illness.In-home mental health treatment for individuals with HIV.Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa.Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest UgandaSubstance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions.Highly stressed: stressful and traumatic experiences among individuals with HIV/AIDS in the Deep SouthAccess to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug useHIV testing among individuals with a severe mental illness: review, suggestions for research, and clinical implicationsRace/ethnicity and HAART initiation in a military HIV infected cohort.Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected UgandansTelephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/AIDS: results of a randomized controlled trial.Toward the integration of comprehensive mental health services in HIV care: an assessment of psychiatric morbidity among HIV-positive individuals in sub-Saharan Africa.Characteristics of HIV-infected adults in the Deep South and their utilization of mental health services: A rural vs. urban comparison.A description of common mental disorders in men who have sex with men (MSM) referred for assessment and intervention at an MSM clinic in Cape Town, South Africa.Depression and patterns of self-reported adherence to antiretroviral therapy in Rwanda.When should we delay highly active antiretroviral therapy?Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast.Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users.Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.Association of unmet needs for support services with medication use and adherence among HIV-infected individuals in the southeastern United States.Psychological distress and engagement in HIV-related services among individuals seeking mental health care.Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women.
P2860
Q28082165-070740A2-F24C-457A-BEB9-51007A113435Q28344328-7E436CED-9406-4771-872A-3BA941F55ADEQ28353070-31AEFD6A-D30F-471F-A8D8-370BFACF35A6Q33563439-664D5F87-1D9C-466F-A6D8-3C1BD1BDF5F1Q33610739-6915A07A-E5A4-4593-A62C-F1B179F036EDQ33716535-131411DE-49F2-424F-B4A9-A8DFE7E73730Q33810905-5C5861F2-6F90-40AA-A878-5082F56F9C7DQ33902792-B78132DB-006E-4674-A5B8-823FCB3638CAQ33978708-1A0524B1-291B-4751-9D94-20892321B8A8Q34743137-FF416B74-C8AC-4BA0-839F-D5E1F8345F36Q34744562-29E4B6D2-0A4F-4B15-BA6F-0EB5A78E4C98Q34745560-10421172-447F-4B98-AD36-F8C662467EF2Q35298291-7241C432-B7D7-4BB2-BED8-371A5C33DCFEQ35526694-1D5CCC3B-3E54-4F9F-88CC-D7C733009AFAQ35545476-669DB476-4AF7-4354-BBD1-8C3C10E16359Q35578711-AC30D600-D061-4B86-A290-121B59E99287Q35580641-DB5F1002-9BBB-4E4A-B0EF-4A91D7EDE68AQ35689100-8CFF69AC-6629-4910-A132-8F2881605A8AQ35925058-49A751A0-2EC5-42CC-96B3-06BACB55684CQ36390123-D3F664B3-C0D3-4667-A763-1D06E3E2B5DBQ36464956-45E98447-CA72-4B5A-91F1-6172E4C8D204Q36666525-9CC5D806-38E0-4A37-AB13-708CB6DE933FQ36952590-71DB489C-BA08-4659-ACCA-F15368470C17Q37058154-B11CCA56-DC2C-4238-9758-BCBEA1A7EE85Q37068828-2CC01978-55F1-47F7-9947-52D769CF7304Q37093067-40E378E6-1D66-48D5-90BB-07022DB7EE3EQ37580896-FECE709B-0C99-4F03-9644-E40302FD293EQ37619648-E941A057-1F0C-4436-BB86-297B99A1E45DQ38452049-D324600B-27E0-4CF4-B398-FFB965E5060BQ39321227-07ECEEED-D922-423E-9946-F59D4620DEA8Q39767068-7E978DE3-E1C9-4537-88AC-76E6897F6CF3Q40101003-6120F78B-88CE-4A46-994E-41F9105C4390Q42218779-BB858E35-30C4-4460-8B00-929D870A4129Q42342425-7211360D-7D23-4EF3-AD35-56570B84E6C2Q43657059-D572FA8A-C51F-404E-9C21-774A49477A6DQ43752658-8F389F47-C3F6-40D7-9EC0-13468D8982FAQ44599505-51704D80-B75F-4EE8-8996-CF035EF265E6Q45022428-138AE528-E54F-4104-83B0-DEAEB3D9FF4DQ45327269-B802537C-6D2F-46A3-BCE4-7698BA9065E7Q46843464-3A985EF3-2795-4F16-B52B-E762D703D6BE
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Delays in protease inhibitor use in clinical practice
@ast
Delays in protease inhibitor use in clinical practice
@en
type
label
Delays in protease inhibitor use in clinical practice
@ast
Delays in protease inhibitor use in clinical practice
@en
prefLabel
Delays in protease inhibitor use in clinical practice
@ast
Delays in protease inhibitor use in clinical practice
@en
P2093
P2860
P1476
Delays in protease inhibitor use in clinical practice
@en
P2093
D M Eisenberg
K M Fairfield
P2860
P304
P356
10.1046/J.1525-1497.1999.08198.X
P577
1999-07-01T00:00:00Z
P5875
P6179
1003245090